Maze Therapeutics: Pay

Maze Therapeutics paid its 3 named executives $9.2M in total in FY2025 (Dec). CEO Jason Coloma, Ph.D. was paid $3.5M of that.

PayNo stock prices for these years

CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Misbah TahirChief Financial Officer


FY2025 (Dec)

1 year

Jason Coloma, Ph.D.Chief Executive Officer


FY2025 (Dec)
FY2024 (Dec)

2 years

Harold Bernstein, M.D., Ph.D.President, Research and Development and Chief Medical Officer


FY2025 (Dec)
FY2024 (Dec)

2 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.